MedTrace Logo

GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

NCT05470751 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2024-04-30

No results posted yet for this study

Summary

Male self catherterisng observational study.

Conditions

  • Bladder Outlet Obstruction
  • Multiple Sclerosis
  • Cauda Equina Syndrome
  • Enlarged Prostate With Lower Urinary Tract Symptoms
  • Parkinson Disease
  • Lower Urinary Tract Symptoms
  • Detrusor Underactivity
  • Spinal Cord Injuries

Interventions

DEVICE

Intermittent self-catheterisation

Self-catheterising with GC Male and Glide Male with Feelclean technology

Sponsors & Collaborators

  • ConvaTec Inc.

    lead INDUSTRY

Principal Investigators

  • Chris Harding · Site Investigator - Newcastle

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-02
Primary Completion
2024-04-06
Completion
2024-04-06

Countries

  • United States
  • France
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05470751 on ClinicalTrials.gov